基本資料
種類: ETF
費用比率%: 0.09
資產淨值: 4,733.68
成立日期: 26/01/2004
 
分析
市值分佈:
95.66%
大市值
2.86%
中市值
0.65%
小市值
持股比例加總可能不達100%,原因包括ETF持有現金或衍生工具。
 
 
行業分佈 國家/地區分佈
 
投資組合
 (更新時間: 25/04/2026 06:00) 總持有投資項目: 405  
0%
 
100%
     10大 (50.46%)
代號 名稱 佔比% 持有日期
ORICOric Pharmaceuticals0.0131/03/2026
BCAXBicara Therapeutics Inc.0.0131/03/2026
JANXJanux Therapeutics0.0131/03/2026
PHATPhathom Pharmaceuticals0.0131/03/2026
SIBNSI-BONE0.0131/03/2026
IRWDIronwood Pharmaceuticals0.0131/03/2026
TYRATyra Biosciences0.0131/03/2026
GLUEMonte Rosa Therapeutics0.0131/03/2026
CRMDCorMedix0.0131/03/2026
SANASana Biotechnology0.0131/03/2026
PHRPhreesia0.0131/03/2026
EMBCEmbecta Corp0.0131/03/2026
MLABMesa Laboratories0.0131/03/2026
HSTMHealthStream0.0131/03/2026
AVBPArriVent BioPharma0.0131/03/2026
OPKOPKO Health0.0131/03/2026
CTKBCytek Biosciences0.0131/03/2026
MDXGMiMedx Group0.0131/03/2026
ANGOAngioDynamics0.0131/03/2026
PRTAProthena Corp0.0131/03/2026
  1    2    3    4    5    6    7    8    9    10    11    12    13    14    15   16    17    18    19    20    21  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.